Neovascular Glaucoma
20
1
4
9
Key Insights
Highlights
Success Rate
82% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
10.0%
2 terminated out of 20 trials
81.8%
-4.7% vs benchmark
5%
1 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (20)
Study to Learn More About Safety of Aflibercept Injection in Japanese Patients With Neovascular Glaucoma (NVG)
Minimally Invasive Suprachoroidal Drainage for the Treatment of Neovascular Glaucoma
Clinical Characteristics of Neovascular Glaucoma
Effect of Subconjunctival 5-fluorouracil on the Outcome of Ahmed Valve in Neovascular Glaucoma
KDR2-2 Suspension Eyedrop in the Treatment of Neovascular Glaucoma (KDR-NVG) Trial
Comparative Study, Safety and Efficacy, Ahmed Glaucoma Drainage Device, Model M4 Model S2 in Neovascular Glaucoma
A Study on the Treatment Strategy of NVG Secondary to PDR
Ahmed Glaucoma Valve Surgery With Mitomycin-C
Use of Intravitreal Aflibercept Injection for Neovascular Glaucoma
Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma
Lucentis for New Onset Neovascular Glaucoma
The Effect of Conbercept Injection Through Different Routes for Neovascular Glaucoma
Oculusgen (Ologen) Glaucoma MMC Control in Estonia
Analysis of Aqueous and Vitreous Humor
Patch Graft Material Safety and Effectiveness in Covering Glaucoma Drainage Device Tube
Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
Study to Evaluate the Effects of Ranibizumab (Lucentis) for Patients With Rubeosis and Neovascular Glaucoma
Effects of Travoprost on Neovascular Glaucoma
Avastin as an Adjunct to Diode Laser in the Treatment of Neovascular Glaucoma
Comparison of Efficacy Between Silicone Ahmed Glaucoma Valves With and Without Intravitreal Triamcinolone Injection